APA (7th ed.) Citation

Zimran, A., Revel-Vilk, S., Dinur, T., Istaiti, M., Botha, J., Lukina, E., . . . Dahl, S. v. (2025, January). Evaluation of Lyso-Gb1 as a biomarker for Gaucher disease treatment outcomes using data from the Gaucher Outcome Survey. Orphanet Journal of Rare Diseases.

Chicago Style (17th ed.) Citation

Zimran, Ari, Shoshana Revel-Vilk, Tama Dinur, Majdolen Istaiti, Jaco Botha, Elena Lukina, Pilar Giraldo, Patrick Deegan, and Stephan vom Dahl. "Evaluation of Lyso-Gb1 as a Biomarker for Gaucher Disease Treatment Outcomes Using Data from the Gaucher Outcome Survey." Orphanet Journal of Rare Diseases Jan. 2025.

MLA (9th ed.) Citation

Zimran, Ari, et al. "Evaluation of Lyso-Gb1 as a Biomarker for Gaucher Disease Treatment Outcomes Using Data from the Gaucher Outcome Survey." Orphanet Journal of Rare Diseases, Jan. 2025.